Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Pelvic lymph nodes and pathways of disease spread in male pelvic malignancies.

O'Shea A, Kilcoyne A, Hedgire SS, Harisinghani MG.

Abdom Radiol (NY). 2019 Oct 31. doi: 10.1007/s00261-019-02285-9. [Epub ahead of print] Review.

PMID:
31673716
2.

Pathways of lymphatic spread in male urogenital pelvic malignancies.

Paño B, Sebastià C, Buñesch L, Mestres J, Salvador R, Macías NG, Nicolau C.

Radiographics. 2011 Jan-Feb;31(1):135-60. doi: 10.1148/rg.311105072. Review.

PMID:
21257939
3.

Lymphatic metastases from pelvic tumors: anatomic classification, characterization, and staging.

McMahon CJ, Rofsky NM, Pedrosa I.

Radiology. 2010 Jan;254(1):31-46. doi: 10.1148/radiol.2541090361. Review.

PMID:
20032141
4.

Pelvic nodal imaging.

Hedgire SS, Pargaonkar VK, Elmi A, Harisinghani AM, Harisinghani MG.

Radiol Clin North Am. 2012 Nov;50(6):1111-25. doi: 10.1016/j.rcl.2012.08.002. Epub 2012 Oct 11. Review.

PMID:
23122041
5.

The role of ultrasound in primary workup of cervical cancer staging (ESGO, ESTRO, ESP cervical cancer guidelines).

Fischerová D, Cibula D.

Ceska Gynekol. 2019 Winter;84(1):40-48. Review.

PMID:
31213057
6.

Management of the lymph nodes in penile cancer.

Heyns CF, Fleshner N, Sangar V, Schlenker B, Yuvaraja TB, van Poppel H.

Urology. 2010 Aug;76(2 Suppl 1):S43-57. doi: 10.1016/j.urology.2010.03.001. Review.

PMID:
20691885
7.

Potential and limitations of diffusion-weighted magnetic resonance imaging in kidney, prostate, and bladder cancer including pelvic lymph node staging: a critical analysis of the literature.

Giannarini G, Petralia G, Thoeny HC.

Eur Urol. 2012 Feb;61(2):326-40. doi: 10.1016/j.eururo.2011.09.019. Epub 2011 Sep 28. Review.

PMID:
22000497
8.

Combined ultrasmall superparamagnetic particles of iron oxide-enhanced and diffusion-weighted magnetic resonance imaging reliably detect pelvic lymph node metastases in normal-sized nodes of bladder and prostate cancer patients.

Thoeny HC, Triantafyllou M, Birkhaeuser FD, Froehlich JM, Tshering DW, Binser T, Fleischmann A, Vermathen P, Studer UE.

Eur Urol. 2009 Apr;55(4):761-9. doi: 10.1016/j.eururo.2008.12.034. Epub 2009 Jan 7.

PMID:
19144456
9.

Ultrasound, CT, MRI, or PET-CT for staging and re-staging of adults with cutaneous melanoma.

Dinnes J, Ferrante di Ruffano L, Takwoingi Y, Cheung ST, Nathan P, Matin RN, Chuchu N, Chan SA, Durack A, Bayliss SE, Gulati A, Patel L, Davenport C, Godfrey K, Subesinghe M, Traill Z, Deeks JJ, Williams HC; Cochrane Skin Cancer Diagnostic Test Accuracy Group.

Cochrane Database Syst Rev. 2019 Jul 1;7:CD012806. doi: 10.1002/14651858.CD012806.pub2.

PMID:
31260100
10.

Laparoscopic pelvic lymph node dissection allows significantly more accurate staging in "high-risk" prostate cancer compared to MRI or CT.

Borley N, Fabrin K, Sriprasad S, Mondaini N, Thompson P, Muir G, Poulsen J.

Scand J Urol Nephrol. 2003;37(5):382-6.

PMID:
14594685
11.
12.

Computed tomography and magnetic resonance imaging evaluation of pelvic lymph node metastasis in bladder cancer.

Li Y, Diao F, Shi S, Li K, Zhu W, Wu S, Lin T.

Chin J Cancer. 2018 Jan 26;37(1):3. doi: 10.1186/s40880-018-0269-0.

13.

Pathways of lymphatic spread in gynecologic malignancies.

Paño B, Sebastià C, Ripoll E, Paredes P, Salvador R, Buñesch L, Nicolau C.

Radiographics. 2015 May-Jun;35(3):916-45. doi: 10.1148/rg.2015140086. Review.

PMID:
25969940
14.

Metastatic lymph nodes in urogenital cancers: contribution of imaging findings.

Morisawa N, Koyama T, Togashi K.

Abdom Imaging. 2006 Sep-Oct;31(5):620-9. Review.

PMID:
17131207
15.

More advantages in detecting bone and soft tissue metastases from prostate cancer using 18F-PSMA PET/CT.

Pianou NK, Stavrou PZ, Vlontzou E, Rondogianni P, Exarhos DN, Datseris IE.

Hell J Nucl Med. 2019 Jan-Apr;22(1):6-9. doi: 10.1967/s002449910952. Epub 2019 Mar 7.

PMID:
30843003
16.

Detection of lymph nodes in pelvic malignancies with Computed Tomography and Magnetic Resonance Imaging.

Saokar A, Islam T, Jantsch M, Saksena MA, Hahn PF, Harisinghani MG.

Clin Imaging. 2010 Sep-Oct;34(5):361-6. doi: 10.1016/j.clinimag.2009.07.004.

PMID:
20813300
17.

Clinical applications of sentinel lymph-node biopsy for the staging and treatment of solid neoplasms.

Gipponi M.

Minerva Chir. 2005 Aug;60(4):217-33. Review. English, Italian.

PMID:
16166921
18.

[Value of imaging for lymph node metastases from renal cell, bladder, prostate, penile, and testicular cancers].

Stattaus J, Bockisch A, Forsting M, Müller SP.

Urologe A. 2005 Jun;44(6):614-24. Review. German.

PMID:
15905989
19.

Combined ultrasmall superparamagnetic particles of iron oxide-enhanced and diffusion-weighted magnetic resonance imaging facilitates detection of metastases in normal-sized pelvic lymph nodes of patients with bladder and prostate cancer.

Birkhäuser FD, Studer UE, Froehlich JM, Triantafyllou M, Bains LJ, Petralia G, Vermathen P, Fleischmann A, Thoeny HC.

Eur Urol. 2013 Dec;64(6):953-60. doi: 10.1016/j.eururo.2013.07.032. Epub 2013 Jul 30.

PMID:
23916692
20.

Staging of genitourinary cancers. The role of diagnostic imaging.

Friedland GW.

Cancer. 1987 Aug 1;60(3 Suppl):450-8.

PMID:
3297284

Supplemental Content

Support Center